## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.89 indicates fundamental undervaluation. Quality metrics strong (ROE 66%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($61.86)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 0)

**1. Las Vegas Sands stock rating upgraded to Buy at Goldman Sachs**
- Source: Investing.com | 20251215T100837 | Bullish | Relevance: 100%
- Goldman Sachs upgraded Las Vegas Sands (NYSE:LVS) to Buy from Neutral, setting an $80 price target due to expected sustained momentum in Macau gaming revenue and strong performance at Marina Bay Sands. The firm expects Las Vegas Sands to maintain high EBITDA, engage in significant share repurchases, and invest in its IR2 project. This upgrade aligns with recent positive analyst updates following the company's stronger-than-expected third-quarter performance.

**2. Las Vegas Sands (NYSE:LVS) Rating Increased to Strong-Buy at Wall Street Zen**
- Source: MarketBeat | 20251213T065830 | Bullish | Relevance: 100%
- Wall Street Zen upgraded Las Vegas Sands (NYSE:LVS) to a "strong-buy" rating, with a consensus "Moderate Buy" from MarketBeat and an average target price of $65.80. This upgrade follows stronger-than-expected quarterly results, where the company reported $0.78 EPS against an expected $0.62 and $3.33 billion in revenue, marking a 24.2% year-over-year increase. Despite recent insider sales totaling approximately 3.1 million shares valued at $194.6 million, institutional investors have been increasing their positions in LVS.

**3. Las Vegas Sands CEO Goldstein sells $26.6 million in stock**
- Source: Investing.com | 20251212T222613 | Neutral | Relevance: 100%
- Robert G. Goldstein, CEO of Las Vegas Sands (NASDAQ: LVS), sold approximately $26.6 million worth of company stock across December 10 and 11, 2025, at prices between $66.39 and $67.03 per share. Concurrently, Goldstein exercised options to acquire 399,900 shares for $20.13 million. Despite the sale, the company shows strong financial health with a "GREAT" score, a P/E of 29.16, and robust gross profit margins of 79.81%, while analysts have raised price targets based on strong performance in Singapore and Macau.

**4. Assessing Las Vegas Sands' Valuation After Strong Q3 2025 Earnings Beat and Sector Outperformance**
- Source: Simply Wall Street | 20251211T130906 | Somewhat-Bullish | Relevance: 100%
- Las Vegas Sands (LVS) exceeded Q3 2025 earnings expectations with strong revenue and EPS growth, particularly driven by Marina Bay Sands. Despite positive momentum and a significant share price return, some valuation models suggest the stock might be overvalued, while others indicate it could be almost 50% undervalued. The article explores different valuation perspectives and potential risks and opportunities for investors.

**5. Goldman Sachs Upgrades Las Vegas Sands to Buy From Neutral, Adjusts PT to $80 From $64**
- Source: marketscreener.com | 20251215T105137 | Bullish | Relevance: 100%
- Goldman Sachs has upgraded Las Vegas Sands (NYSE:LVS) to a "Buy" rating from "Neutral," significantly increasing its price target to $80 from $64. This upgrade indicates a more positive outlook for the casino and resorts operator. The article also provides recent insider transaction data and analyst recommendations from other firms.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($13.25M) |
| Sells | 12 ($64.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Heavy insider selling: $65M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.89 indicates undervaluation relative to growth. Forward P/E 20.5x stretched relative to 9% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (2 raises, avg +12%). Insider selling cluster ($64.9M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $44.8B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.89 |
| Forward P/E | 20.5 |
| Current P/E | 22.5 |
| YoY Growth | 9.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.9% to -1.9% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >4.0% for momentum thesis). Underperforming sector by 4.9pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.32x) but short-term weakness (below SMA20). MACD histogram bearish (-0.59), momentum weakening. RSI neutral at 52. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.93% (CS: 22) | Neutral |
| RSI_14 | 52.0 | Neutral |
| MACD Histogram | -0.59 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 1.082x | Above |
| vs SMA200 | 1.325x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $65.24
- **Stop Loss:** $61.86 (5.2% risk)
- **Target:** $72.00 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 355
- **Position Value:** $23,160.20
- **Portfolio %:** 23.16%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*